Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DULOXETINE HYDROCHLORIDE

DULOXETINE HYDROCHLORIDE

Standard Dose
60MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview DULOXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 090775 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient DULOXETINE HYDROCHLORIDE Form and strength CAPSULE, DELAYED RELEASE; ORAL - 60MG Sponsor SANDOZ Submission history Latest submission status date: 2011-02-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview DULOXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 090775 (ANDA). Marketing status: None (Tentative Approval) Active ingredient DULOXETINE HYDROCHLORIDE Form and strength CAPSULE, DELAYED RELEASE; ORAL - 60MG Sponsor SANDOZ Submission history Latest submission status date: 2011-02-02 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.